http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PT-3185867-T

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d79362493392629399a529d819cdccd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2697de8d254f6515604d2cf59730970
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
filingDate 2015-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PT-3185867-T
titleOfInvention CRYSTALLIZATION PROCESS OF ARIPIPRAZOL DERIVATIVES IN PROLONGED RELEASE FORMULATIONS FOR TREATMENT OF SCHIZOPHRENIA
priorityDate 2014-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60795

Total number of triples: 16.